BioSpace News Archive

Altamira Therapeutics positions its peptide-based SemaPhore™ nanoparticle technology as a versatile and efficient alternative to the hitherto dominant lipid nanoparticle (LNP) delivery technologies in the fast growing field of mRNA (messenger ribonucleic acid) applications.

Aurinia Pharmaceuticals Announces New and Refined Method of Use Patent for LUPKYNIS ® in the Treatment of Lupus Nephritis Issued by United States Patent and Trademark Office.

A new recruitment business that provides services for senior and technical roles in the informatics sector opens its doors today.

Medibiofarma, a biopharmaceutical company developing novel therapies for gastrointestinal diseases and other indications, announced receipt of funding from the Crohn’s & Colitis Foundation’s IBD Ventures

ImmuneBridge today announced the close of an oversubscribed $12 million seed financing co-led by global investors Insight Partners and M Ventures, the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany.

Akebia Therapeutics, Inc. announced that it adjourned, without conducting any business, the special meeting of stockholders on Tuesday, April 11, 2023 to allow the company to solicit from its stockholders the additional proxies necessary to obtain approval of the proposals described in the company’s revised definitive proxy statement filed with the Securities and Exchange Commission on March 17, 2023.

Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company.

MaaT Pharma announced that promising clinical data for its drug candidates, MaaT013 and MaaT033 will be reported in two oral presentations by Pr. Florent Malard, Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University during the 49th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2023).

Aitia, announced today that data from its Multiple Myeloma Digital Twin model will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting being held from April 14-19 in Orlando, Florida.

Magnolia Medical Technologies, Inc., announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of 19 new Steripath® Micro configurations within the company’s ISDD® product portfolio.